Transdermal Patches – De-risking concept for the in virto to in vivo translation using new prediction tools
November 19, 2021
Watch our webcast with Marco Emgenbroich and May Pidding talking about “TRANSDERMAL PATCHES – De-risking concept for the in vitro to in vivo translation using new prediction tools”. It will help you to understand the potential of TTS and give you insights about the rational development approach by combination of in vitro and in silico methods. In several use cases we show the formulation and manufacturing approaches for the development of new or generic transdermal systems for a systemic or local drug delivery.
Presented by Dr. Marco Emgenbroich, Corporate Vice President Head of Pharmaceutical Development, and Dr. May Pidding, Director US Business Development